Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients With Pyoderma Gangrenosum
Brief Summary: The study will evaluate the long-term safety of gevokizumab in treating active PG ulcers